Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Annual Information Update

28th May 2009 18:27

RNS Number : 9887S
Vernalis PLC
28 May 2009
 



VERNALIS PLC

ANNUAL INFORMATION UPDATE

As required under Prospectus Rule 5.2, and following publication of the Annual Report on 29th April 2009the following summarises the information and documents published or made available to the public by the Company between 26th June 2008 and 28th May 2009 inclusive.

This Annual Information Update is also being made available on the Investors section of the Company's website at www.vernalis.com.

The information referred to in this Annual Information Update was correct at the time it was published but some information may now be out of date.

1. Announcements made via a Regulatory Information Service ("RIS")

 

Date 

Description of Contents of Announcement

26/06/2008

Annual Information Update

30/06/2008

Extraordinary General Meeting Statement

01/07/2008

Completion of Sale of Apokyn® and US Commercial Operations and Share Subscription

07/07/2008

Notification of Major Interests in Shares

08/07/2008

Holding(s) in Company

19/08/2008

Notice of 2008 Half Year Results

28/08/2008

Interim Results - Part 1

28/08/2008

Interim Results - Part 2

28/08/2008

Interim Results - Part 3

03/09/2008

Holding(s) in Company

13/10/2008

Research Update in Relation to Reaching Milestone in Oncology Drug Programme

17/10/2008

Holding(s) in Company

21/10/2008

Holding(s) in Company

22/10/2008

Pipeline Update in Relation to Re-acquisition of a Phase II Ready Anti-Inflammatory Drug Candidate

28/10/2008

Directorate Change

14/11/2008

Interim Management Statement

14/11/2008

Appointment of New CEO and New CFO

19/11/2008

Director Directorships Declaration

22/12/2008

Holding(s) in Company

24/12/2008

Holding(s) in Company

29/12/2008

Director/PDMR Shareholding

27/03/2009

Pipeline Update in Relation to Partner, Biogen Idec, Reporting Favourable Data from Phase IIa Parkinson's Disease Studies of BIIB014 (Licensed from the Company)

29/04/2009

Final Results - Part 1

29/04/2009

Final Results - Part 2

29/04/2009

Final Results - Part 3

29/04/2009

Placing and Open Offer - Part1

29/04/2009

Placing and Open Offer - Part 2

29/04/2009

Notice of 2008 Annual Report and Accounts

30/04/2009

Publication of Prospectus

07/05/2009

New 3 Year Collaboration with Servier

13/05/2009

Director/PDMR Shareholding

18/05/2009

Results of Placing and Open Offer

18/05/2009

Results of General Meeting

19/05/2009

General Meeting Resolutions and Voting Rights and Capital

20/05/2009

Holding(s) in Company

20/05/2009

Director/PDMR Shareholding

21/05/2009

AGM + Annual Report Notice

21/05/2009

Holding(s) in Company

21/05/2009

Director/PDMR Shareholding - Amendment

All of the above UK regulatory announcements have been made via a RIS and can be obtained from the London Stock Exchange's website at www.londonstockexchange.com or the Company's website at www.vernalis.com. 

2. Documents filed at Companies House

All the documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated.

Date

Document Type

09/07/2008

Memorandum and Articles of Association

11/07/2008

Annual Report and Accounts

11/07/2008

Annual General Meeting Resolutions

11/07/2008

Extraordinary General Meeting Resolutions

11/07/2008

Form 123 - Notice of Increase in Nominal Capital

11/07/2008

Form 88(2) - Return of Allotment of Shares

16/08/2008

Form 363s - Annual Return

29/11/2008

Form 288b - Terminating Appointment of Director

13/01/2009

Form 288a - Appointment of Director

13/02/2009

Form 288a - Appointment of Director

18/05/2009

General Meeting Resolutions

18/05/2009

Memorandum and New Articles of Association

18/05/2009

Form 122 - Notice of Subdivision and Consolidation of Share Capital

18/05/2009

Form 169 - Notice of Purchase of Deferred and A Deferred Shares

Copies of the above documents, filed with the Registrar of Companies, can be obtained from the Companies House website at www.companieshouse.gov.uk, or can be obtained from Companies House, Crown WayCardiffCF14 3UZ.

 

3. Documents published or sent to Shareholders or filed with the UK Listing Authority or submitted to the FSA

All the documents below were submitted to the FSA/UKLA on or around the dates indicated.

Date

Document

25/06/2008

Application for Admission of Securities to the Official List

25/06/2008

Form 1 - Application for Admission of Securities to Trading

28/08/2008

Interim Report

29/04/2009

Annual Report

29/04/2009

Prospectus and Notice of General Meeting

12/05/2009

Application for Admission of Securities to the Official List

12/05/2009

Form 1 - Application for Admission of Securities to Trading

18/05/2009 

General Meeting Resolutions

21/05/2009

Notice of Annual General Meeting

Certain documents submitted to the FSA can be viewed at the Document Viewing Facility situated at The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London, E14 5HS.

The Notice of Annual General Meeting and Annual, Interim and Preliminary Reports are also available via the Investors section of the Company's website at www.vernalis.com.

4. Further Information

Further information about Vernalis plc can be found on the Company's website at www.vernalis.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUZGGZKNRVGLZM

Related Shares:

Vernalis PLC
FTSE 100 Latest
Value8,875.22
Change24.59